Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
    2.
    发明授权
    Thienylazolylalcoxyethanamines, their preparation and their application as medicaments 失效
    噻吩并噻唑基羟乙胺,它们的制备及其作为药物的应用

    公开(公告)号:US06410582B1

    公开(公告)日:2002-06-25

    申请号:US09673186

    申请日:2000-10-12

    IPC分类号: A61K3141

    摘要: The thienylazolylalkoxyethanamines (I) where R1 is a hydrogen atom, a halogen atom or a lower alkyl radical; R2, R3 and R4 represent, independently, a hydrogen atom or a lower alkyl radical; and Az represents a five-member nitrogenated hetercyclic aromatic group, N-methyl-substituted, that contains from one to three nitrogen atoms. They have analgesic activity in mammals, including humans. The compounds (I) can be obtained, for example, by reaction of a derivative of hydroxy-thienylazol (IV) with a derivative of a suitable N-(ethyl)amine. The compounds (IV) are useful intermediates in the synthesis of the compounds (I). The compounds (I) have an application in human and/or veterinary medicine.

    摘要翻译: 其中R 1是氢原子,卤素原子或低级烷基的噻吩基唑烷基乙胺(I) R2,R3和R4独立地表示氢原子或低级烷基; 并且Az表示含有一至三个氮原子的五元氮杂环芳族基团N-甲基取代基。 它们在哺乳动物,包括人类中具有止痛活性。 化合物(I)可以通过例如羟基噻吩唑(IV)的衍生物与合适的N-(乙基)胺衍生物的反应来获得。 化合物(IV)是化合物(I)的合成中的有用的中间体。 化合物(I)在人和/或兽医学中有应用。